Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-08 Purchase | 2022-07-13 9:27 pm | Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner | 19,270,476 | $2.2 | $42,395,047 | 76,616,270 (Indirect Direct) | View |
| 2022-03-31 Purchase | 2022-04-01 4:52 pm | Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner | 5,385,208 | $5 | $26,926,040 | 44,441,416 (Indirect Direct) | View |
| 2022-02-09 Purchase | 2022-02-11 6:56 pm | Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner | 3,614,792 | $5 | $18,073,960 | 36,363,604 (Indirect Direct) | View |
| 2021-10-29 Purchase | 2021-11-01 2:20 pm | Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner | 1,212,122 | $3.3 | $4,000,003 | 16,076,769 (Indirect Direct) | View |
| 2021-06-11 Purchase | 2021-06-11 5:39 pm | Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner | 6,268,975 | $2 | $12,537,950 | 57,345,794 (Indirect Direct) | View |
| 2021-05-03 Purchase | 2021-05-20 2:39 pm | Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner | 3,731,025 | $2 | $7,462,050 | 44,807,844 (Indirect Direct) | View |
| 2021-03-17 Purchase | 2021-03-17 5:16 pm | Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner | 4,285,935 | $3.25 | $13,929,289 | 29,729,294 (Indirect Direct) | View |
| 2021-01-26 Purchase | 2021-01-28 1:43 pm | Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner | 1,867,912 | $3.25 | $6,070,714 | 21,157,424 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-18 Other | 2022-02-23 1:05 pm | N/A 2022-08-18 | Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner | 0 | $0 | 57,345,794 (Indirect) | View |